Clinical trials center joins ProSciento’s program for NASH trial recruitment

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Klenger)
(Image: Getty/Klenger)

Related tags: Clinical trials, trial recruitment, Clinical research, NASH, CRO

High Point Clinical Trials Center is partnering with ProSciento to accelerate clinical trial recruitment of patients with NASH and NAFLD.

High Point Clinical Trials Center enters a three-year collaboration with ProSciento, a contract research organization (CRO) focused on metabolic diseases, as the center becomes a NASH PASS site partner.

The NASH PASS program from ProSciento matches sites with its proprietary methodology to improve enrollment outcomes in clinical trials for non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD).

Lorraine Rusch, president of HPCTC, told us that the center – which focuses on Phase I/II clinical proof of concept and translational medicine studies – was interested in the partnership because of the metrics-driven approach ProSciento uses as a means to drive faster recruitment of ”very valuable” patients in a quantitative manner. 

Through this partnership, HPCTC will use the NASH PASS protocol to identify individuals eligible for enrollment and contribute to the programs database of prospective clinical study participants evaluated for NAFLD and NASH studies. The center will use a combination of transient elastography (fibroscan), proprietary algorithms, and non-invasive biomarker testing, to determine enrollment eligibility.

In a statement, Rusch added: “These much-needed efforts will spur rapid recruitment of patients into clinical trials which directly translates into novel pharmaceutical products and new methodologies for earlier treatment of this emerging metabolic epidemic.”

Related news

Show more

Related products

show more

QPS: Global Custom-Built Research Services

QPS: Global Custom-Built Research Services

QPS | 16-Dec-2019 | Product Brochure

Performing complex studies in special populations with remarkable agility. Clinical research just got better with QPS’ Custom-Built Research Services....

Validating The Simoa Technology

Validating The Simoa Technology

Frontage Laboratories | 01-Oct-2019 | Technical / White Paper

Frontage is the first and only laboratory to validate Quanterix’ Simoa HD1 Analyzer for performing immunoassays. Most of the advanced instruments used...

Related suppliers

Follow us

Products

View more

Webinars